UCB-J

DRUG2 trials

Sponsors

Region Stockholm – SLSO, University of Wisconsin, Madison

Conditions

Alzheimer DiseaseMajor Depressive DisorderMalignant tumours ICD 10 C00 to C97

Phase 2

The Synapse Project

CompletedNCT04871074

University of Wisconsin, MadisonAlzheimer Disease

Start: 2018-11-18End: 2025-05-01Updated: 2026-06-26

CAPSI - Cancer related major depression treated with a single dose of psilocybin - a multicenter randomized placebo controlled double blind clinical trial

RecruitingCTIS2023-505532-35-00

Region Stockholm – SLSOMajor Depressive Disorder, Malignant tumours ICD 10 C00 to C97

Start: 2024-05-15Target: 120Updated: 2025-05-07

Related Papers

Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression.

2026-04-09